We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
(+7.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$193M |
| 2 |
Gilead Sciences
GILD
|
+$115M |
| 3 |
Tencent Music
TME
|
+$83.5M |
| 4 |
Kanzhun
BZ
|
+$76.7M |
| 5 |
Wheaton Precious Metals
WPM
|
+$68.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$189M |
| 2 |
Williams Companies
WMB
|
+$155M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$94.1M |
| 4 |
AbbVie
ABBV
|
+$87M |
| 5 |
Amgen
AMGN
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.44% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Titan International
TWI
$461M
| $9.73K | ﹤0.01% |
781
+4
| +0.5% | +$55 |
|
1777
Group 1 Automotive
GPI
$3.24B
| $9.64K | ﹤0.01% |
33
-81
| -71% | -$22.1K |
|
|
EGRX
1778
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $9.59K | ﹤0.01% |
1,830
+642
| +54% | +$3.52K |
|
1779
CytomX Therapeutics
CTMX
$608M
| $9.57K | ﹤0.01% |
4,388
+903
| +26% | +$1.67K |
|
1780
Bioventus
BVS
$902M
| $9.56K | ﹤0.01% |
1,839
| – | – |
|
1781
iShares MSCI Japan Value ETF
EWJV
$792M
| $9.5K | ﹤0.01% |
286
| – | – |
|
1782
Conduent
CNDT
$252M
| $9.46K | ﹤0.01% |
2,798
-2,876
| -51% | -$9.98K |
|
1783
Apple Hospitality REIT
APLE
$3.69B
| $9.44K | ﹤0.01% |
576
-7,162
| -93% | -$117K |
|
1784
Nature's Sunshine
NATR
$233M
| $9.43K | ﹤0.01% |
454
-26
| -5% | -$471 |
|
1785
Annexon
ANNX
$751M
| $9.2K | ﹤0.01% |
+1,283
| New | +$6.66K |
|
1786
HSBC
HSBC
$349B
| $9.13K | ﹤0.01% |
232
+15
| +7% | +$586 |
|
1787
IES Holdings
IESC
$12.8B
| $9.12K | ﹤0.01% |
150
| – | – |
|
1788
Clearwater Paper
CLW
$341M
| $9.1K | ﹤0.01% |
+208
| New | +$7.67K |
|
|
ORGN
1789
DELISTED
Origin Materials
ORGN
| $9.05K | ﹤0.01% |
591
+438
| +286% | +$7.6K |
|
1790
Lincoln Educational Services
LINC
$801M
| $8.97K | ﹤0.01% |
868
-214
| -20% | -$2.08K |
|
|
GTHX
1791
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $8.78K | ﹤0.01% |
2,032
+613
| +43% | +$2.14K |
|
|
WHWK
1792
Whitehawk Therapeutics
WHWK
$234M
| $8.69K | ﹤0.01% |
3,714
+3,259
| +716% | +$6.28K |
|
|
LPSN
1793
DELISTED
LivePerson
LPSN
| $8.64K | ﹤0.01% |
578
-53,252
| -99% | -$1.83M |
|
1794
ANI Pharmaceuticals
ANIP
$1.67B
| $8.3K | ﹤0.01% |
120
+7
| +6% | +$423 |
|
1795
Immunome
IMNM
$2.72B
| $8.27K | ﹤0.01% |
335
+248
| +285% | +$5.03K |
|
|
TRML
1796
DELISTED
Tourmaline Bio
TRML
| $8.18K | ﹤0.01% |
357
+213
| +148% | +$7.51K |
|
1797
Jack in the Box
JACK
$252M
| $8.15K | ﹤0.01% |
119
-81
| -41% | -$6.1K |
|
1798
Universal Electronics
UEIC
$66.9M
| $8.09K | ﹤0.01% |
808
-243
| -23% | -$2.18K |
|
1799
La-Z-Boy
LZB
$1.22B
| $7.94K | ﹤0.01% |
211
+1
| +0.5% | +$37 |
|
|
THRD
1800
DELISTED
Third Harmonic Bio
THRD
| $7.92K | ﹤0.01% |
839
| – | – |
|
Similar funds
Federated Hermes's Q1 2024 Portfolio in Review
As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
- Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
- Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
- Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
- Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
- Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
- Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.